Lv21
110 积分 2023-09-19 加入
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes
59分钟前
待确认
Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study
8天前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
27天前
已完结
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
28天前
已完结
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
28天前
已完结
Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD
1个月前
已完结
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
1个月前
已完结
Glucagon acts in the liver to control spontaneous meal size in rats
1个月前
已完结
Dose-related suppression of feeding by intraportal glucagon infusion in the rat
1个月前
已完结
Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD
1个月前
已完结
皖公网安备34019202002308
